CY1116161T1 - Kit για παρεντερικη χορηγηση φαρμακων - Google Patents

Kit για παρεντερικη χορηγηση φαρμακων

Info

Publication number
CY1116161T1
CY1116161T1 CY20151100318T CY151100318T CY1116161T1 CY 1116161 T1 CY1116161 T1 CY 1116161T1 CY 20151100318 T CY20151100318 T CY 20151100318T CY 151100318 T CY151100318 T CY 151100318T CY 1116161 T1 CY1116161 T1 CY 1116161T1
Authority
CY
Cyprus
Prior art keywords
kit
medicines
parental administration
injection
administration
Prior art date
Application number
CY20151100318T
Other languages
English (en)
Inventor
Flavio Villani
Paolo Magri'
Original Assignee
Infa S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infa S.A. filed Critical Infa S.A.
Publication of CY1116161T1 publication Critical patent/CY1116161T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Η εφεύρεση αφορά σε ένα κιτ για παρεντερική χορήγηση φαρμάκων, ιδιαιτέρως ένα κιτ για την έγχυση αυτών των φαρμάκων διαλελυμένων σε διαλύτες που εκχυλίζουν τοξικά συστατικά από PVC, που επίσης είναι κατάλληλο για την έγχυση πολύ δραστικών φαρμάκων, το εν λόγω δε κιτ διασφαλίζει ασφαλή χορήγηση τόσο για τον ασθενή όσο και για το προσωπικό φροντίδας υγείας.
CY20151100318T 2005-09-29 2015-04-02 Kit για παρεντερικη χορηγηση φαρμακων CY1116161T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001826A ITMI20051826A1 (it) 2005-09-29 2005-09-29 Kit per la somministrazione parenterale di medicamenti
EP06842195.7A EP1928501B1 (en) 2005-09-29 2006-09-29 Kit for parenteral administration of medicaments

Publications (1)

Publication Number Publication Date
CY1116161T1 true CY1116161T1 (el) 2017-02-08

Family

ID=37900123

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100318T CY1116161T1 (el) 2005-09-29 2015-04-02 Kit για παρεντερικη χορηγηση φαρμακων

Country Status (27)

Country Link
US (1) US8182449B2 (el)
EP (1) EP1928501B1 (el)
JP (1) JP2009509608A (el)
KR (1) KR20080058389A (el)
CN (1) CN101316614A (el)
AU (1) AU2006296350B2 (el)
BR (1) BRPI0617588A2 (el)
CA (1) CA2624047C (el)
CY (1) CY1116161T1 (el)
DK (1) DK1928501T3 (el)
ES (1) ES2534416T3 (el)
HK (1) HK1117420A1 (el)
HR (1) HRP20150393T1 (el)
HU (1) HUE024968T2 (el)
IL (1) IL190323A (el)
IT (1) ITMI20051826A1 (el)
MD (1) MD20080116A (el)
NO (1) NO20081559L (el)
PL (1) PL1928501T3 (el)
PT (1) PT1928501E (el)
RS (1) RS53934B1 (el)
RU (1) RU2446828C2 (el)
SI (1) SI1928501T1 (el)
TN (1) TNSN08144A1 (el)
UA (1) UA93060C2 (el)
WO (1) WO2007036792A2 (el)
ZA (1) ZA200802745B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774826A1 (en) * 2009-10-30 2011-05-05 Revance Therapeutics, Inc. Device and method for topical application of therapeutic or cosmetic compositions
PL3238709T3 (pl) 2011-04-28 2021-02-08 Platform Brightworks Two, Ltd. Ulepszone preparaty pozajelitowe lipofilowych środków farmaceutycznych oraz sposoby ich wytwarzania i stosowania
CN103508077A (zh) * 2012-06-25 2014-01-15 贵州益佰制药股份有限公司 一种药物包装系统及静脉给药的试剂盒
EP3823608A4 (en) * 2018-09-05 2022-05-11 Emcure Pharmaceuticals Limited STABLE READY-TO-USE PHARMACEUTICAL CARMUSTI COMPOSITION
US20220062288A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Pharmaceutical compositions of vibegron for reducing body fat
US20220062213A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Methods and compositions of solabegron for reducing body fat
WO2023049747A1 (en) * 2021-09-22 2023-03-30 Elanco Us Inc. Streptococcus suis lytic enzyme compositions and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3730338A (en) * 1971-03-04 1973-05-01 Kendall & Co Sterile shielded container
US5536413A (en) * 1990-12-03 1996-07-16 Pall Corporation Method for treating a parenteral emulsion-containing medicament fluid
US6232477B1 (en) * 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
JPH105342A (ja) * 1996-06-27 1998-01-13 A S A Sangyo Kk 経腹膜投薬用カテーテル及び投薬容器セット
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
SE9703425D0 (sv) * 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
JP2002529204A (ja) * 1998-11-13 2002-09-10 エラン・フアルマ・インターナシヨナル・リミテツド 薬品を給送するシステム及び方法
AUPQ078799A0 (en) * 1999-06-04 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. New use
US6979461B1 (en) * 1999-10-18 2005-12-27 Fujisawa Pharmaceutical Co., Ltd. Method for producing liposome preparation
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
US6489335B2 (en) * 2000-02-18 2002-12-03 Gholam A. Peyman Treatment of ocular disease
JP2002052067A (ja) * 2000-08-09 2002-02-19 Kyowa Medex Co Ltd 用時薬剤溶解器具、用時溶解型キット製剤用容器及び用時溶解型キット製剤
DK1392254T3 (da) * 2001-04-20 2007-07-02 Univ British Columbia Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
WO2002087563A2 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
JP4002747B2 (ja) * 2001-10-26 2007-11-07 株式会社大塚製薬工場 薬剤混合用アダプタおよびそれを備える溶解液容器
GB2388025A (en) * 2002-04-06 2003-11-05 Pharmaceutical Bulk Substances Kit for preparing a formulation of paclitaxel
JP4427965B2 (ja) * 2002-07-02 2010-03-10 ニプロ株式会社 連通手段付き薬液容器
US7488309B2 (en) * 2002-07-03 2009-02-10 Bioanalytical Systems, Inc. Device and method for drug delivery to animals
EP1558241A2 (en) * 2002-11-08 2005-08-03 Bristol-Myers Squibb Company Pharmaceutical compositions and methods of using taxane derivatives
EP1599212A4 (en) * 2003-02-14 2006-02-08 Combinatorx Inc POLYTHERAPY FOR THE TREATMENT OF IMMUNO-INFLAMMATORY DISORDERS
EP1735293A2 (en) * 2004-03-09 2006-12-27 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamine aspartyl protease inhibitors

Also Published As

Publication number Publication date
EP1928501A2 (en) 2008-06-11
WO2007036792A2 (en) 2007-04-05
AU2006296350A1 (en) 2007-04-05
TNSN08144A1 (en) 2009-07-14
CA2624047A1 (en) 2007-04-05
ZA200802745B (en) 2009-05-27
ITMI20051826A1 (it) 2007-03-30
PT1928501E (pt) 2015-04-23
CN101316614A (zh) 2008-12-03
DK1928501T3 (en) 2015-04-20
EP1928501B1 (en) 2015-01-07
RS53934B1 (en) 2015-08-31
PL1928501T3 (pl) 2015-07-31
SI1928501T1 (sl) 2015-06-30
NO20081559L (no) 2008-06-12
MD20080116A (ro) 2008-10-31
UA93060C2 (ru) 2011-01-10
IL190323A (en) 2014-07-31
KR20080058389A (ko) 2008-06-25
JP2009509608A (ja) 2009-03-12
BRPI0617588A2 (pt) 2011-08-02
ES2534416T3 (es) 2015-04-22
RU2008116812A (ru) 2009-11-10
WO2007036792A3 (en) 2007-08-30
HRP20150393T1 (hr) 2015-05-22
US20090264830A1 (en) 2009-10-22
HK1117420A1 (en) 2009-01-16
CA2624047C (en) 2016-01-05
IL190323A0 (en) 2009-09-22
HUE024968T2 (en) 2016-02-29
AU2006296350B2 (en) 2012-08-30
RU2446828C2 (ru) 2012-04-10
US8182449B2 (en) 2012-05-22

Similar Documents

Publication Publication Date Title
CY1116161T1 (el) Kit για παρεντερικη χορηγηση φαρμακων
CY1123050T1 (el) Φαρμακα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
ECSP066734A (es) Derivados de ácido 7-fenilamino-4-quinolona-3-carboxílico, métodos para su producción y su uso como medicamentos
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
CY1116552T1 (el) Ανοσοθεραπευτικα σχηματα εξαρτωμενα απο την κατασταση αροε
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
CY1117312T1 (el) Θεραπευτικη αγωγη συνουκλεϊνοπαθειων
AR071187A1 (es) Compuesto de arilmetil-tiazinamina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento de la enfermedad de alzheimer
CY1121480T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν δοτες νιτροξυλιου
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
EA200802204A1 (ru) Применение ингибиторов dpp iv
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
ATE470151T1 (de) Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
CY1111541T1 (el) Αγωνιστες β-2 αδρενοϋποδοχεα για την αγωγη παθησεων συνδετικου ιστου του δερματος
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
ATE485037T1 (de) Krebsbehandlung mittels fts und 2-deoxyglucose
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
EA201590797A1 (ru) Препараты с модифицированным высвобождением опрозомиба
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
IS8413A (is) Læknisfræðileg meðferðaráform til inngjafar á lyfjasamsetningum